D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Apple
AAPL
|
+$1.22B |
| 3 |
T-Mobile US
TMUS
|
+$889M |
| 4 |
Micron Technology
MU
|
+$887M |
| 5 |
Netflix
NFLX
|
+$828M |
Top Sells
| 1 |
Robinhood
HOOD
|
+$1.02B |
| 2 |
GE Vernova
GEV
|
+$976M |
| 3 |
Charles Schwab
SCHW
|
+$582M |
| 4 |
TSMC
TSM
|
+$572M |
| 5 |
Microsoft
MSFT
|
+$564M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 12.06% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Financials | 9.02% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Fidelity MSCI Utilities Index ETF
FUTY
$1.98B
| $827K | ﹤0.01% |
15,728
-15,679
| -50% | -$825K |
|
2202
John B. Sanfilippo & Son
JBSS
$737M
| $827K | ﹤0.01% |
13,081
+131
| +1% | +$8.28K |
|
2203
CVR Energy
CVI
$3.13B
| $827K | ﹤0.01% |
30,809
-42,043
| -58% | -$1.13M |
|
2204
Occidental Petroleum Corporation Warrants to Purchase Common Stock
OXY.WS
$22.5B
| $826K | ﹤0.01% |
39,904
| – | – |
|
2205
OceanFirst Financial
OCFC
$1.04B
| $821K | ﹤0.01% |
46,612
-27,919
| -37% | -$492K |
|
|
GOOD
2206
Gladstone Commercial Corp
GOOD
$608M
| $819K | ﹤0.01% |
57,179
-42,691
| -43% | -$612K |
|
2207
International Paper
IP
$24.3B
| $818K | ﹤0.01% |
17,467
-1,207,479
| -99% | -$56.5M |
|
2208
Krispy Kreme
DNUT
$541M
| $818K | ﹤0.01% |
281,038
+64,973
| +30% | +$189K |
|
2209
Mesa Laboratories
MLAB
$339M
| $816K | ﹤0.01% |
+8,665
| New | +$816K |
|
2210
Ligand Pharmaceuticals
LGND
$3.23B
| $813K | ﹤0.01% |
+7,151
| New | +$813K |
|
2211
Kura Oncology
KURA
$711M
| $812K | ﹤0.01% |
140,713
-278,275
| -66% | -$1.61M |
|
2212
Build-A-Bear
BBW
$977M
| $810K | ﹤0.01% |
15,719
-13,881
| -47% | -$716K |
|
2213
Sealed Air
SEE
$4.99B
| $804K | ﹤0.01% |
+25,926
| New | +$804K |
|
2214
Descartes Systems
DSGX
$8.96B
| $803K | ﹤0.01% |
7,900
+1,300
| +20% | +$132K |
|
2215
iShares Russell 2500 ETF
SMMD
$1.66B
| $803K | ﹤0.01% |
11,853
| – | – |
|
2216
Synaptics
SYNA
$2.72B
| $802K | ﹤0.01% |
12,375
-37,940
| -75% | -$2.46M |
|
2217
Praxis Precision Medicines
PRAX
$794M
| $801K | ﹤0.01% |
19,056
+6,848
| +56% | +$288K |
|
2218
Lattice Semiconductor
LSCC
$8.82B
| $801K | ﹤0.01% |
16,349
+9,398
| +135% | +$460K |
|
2219
Gorman-Rupp
GRC
$1.13B
| $800K | ﹤0.01% |
21,790
+10,030
| +85% | +$368K |
|
2220
Centuri Holdings
CTRI
$2.04B
| $800K | ﹤0.01% |
+35,648
| New | +$800K |
|
2221
Akebia Therapeutics
AKBA
$782M
| $797K | ﹤0.01% |
219,089
+145,928
| +199% | +$531K |
|
|
BKHA
2222
Black Hawk Acquisition Corp
BKHA
$45.9M
| $797K | ﹤0.01% |
75,000
| – | – |
|
2223
Bio-Rad Laboratories Class A
BIO
$7.59B
| $796K | ﹤0.01% |
3,300
-15,625
| -83% | -$3.77M |
|
2224
iShares JPMorgan EM Corporate Bond ETF
CEMB
$400M
| $794K | ﹤0.01% |
+17,471
| New | +$794K |
|
|
NPKI
2225
NPK International Inc.
NPKI
$889M
| $793K | ﹤0.01% |
93,220
+10,461
| +13% | +$89K |
|